Carmen Guerra, MD, MSCE, FACP, is a general internist and professor of medicine at the University of Pennsylvania's Perelman School of Medicine.
Carmen Guerra, MD, MSCE, FACP, is a general internist and professor of medicine at the University of Pennsylvania's Perelman School of Medicine. She is being honored at the Association of Community Cancer Centers' National Oncology Conference with the 2022 Clinical Research Award for her contributions to cancer equity.
Her work focuses on disease prevention, screening and early detection, treatment, and survivorship, and within those, access to cancer screening tests for underserved and underresourced populations and overcoming barriers to access to cancer clinical trials.
Transcript
What are you most looking forward to learning at the ACCC National Oncology Conference?
Well, that is a tough question, because there’s so much that I’m looking forward to at the ACCC National Oncology Meeting and learning from. When you look at their agenda, boy, they didn’t shy away from any tough challenges that we’re facing in oncology today.
They address topics such as the great resignation, burnout, and well-being, which is really threatening the field of oncology. Approximately a third to even a half of oncologists experience some form of burnout, especially after COVID[-19], and so that’s a big threat. I think there’re also [sessions] on social determinants of health and of course my [session] on unconscious bias.
But really, overall, I’m looking forward to being with a similar community in thought that isn’t shy and afraid to tackle the really tough problems in oncology, because it’s really going to take all of us to address these very complex multilevel problems. It’s a wonderful community, and I’m really looking forward to just being part of that process and conversation and discussion and reflection.
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Zanubrutinib Shows Durable Benefit for High-Risk CLL/SLL at 5 Years in SEQUOIA Trial
June 6th 2025Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and deletion of the 17p chromosome, with progression-free survival similar to patients without high-risk disease characteristics.
Read More
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
At EHA 2025, Hematology Discussions Will Stretch Across Lifespans and Locations
June 5th 2025The 2025 European Hematology Association (EHA) Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in hematology and oncology.
Read More